GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Abingdon Health ABDX.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

8.75p

-2.78%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2026

Revenue

£11.0m

FY2016FY2026

Net income

−£2.1m

FY2016FY2026

Free cash flow

−£1.8m

FY2016FY2026

Shareholders' equity

£6.1m

FY2016FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2016
Revenue£11.0m£8.4m£6.1m£4.0m£2.8m£11.6m£5.2m£2.3m£2.3m£1.4m
Gross profit£5.2m£3.1m£3.7m£1.4m−£5.2m£3.4m£4.1m£1.6m£1.3m£1.1m
Research and development————£182,000£503,000£854,000£210,731£285,043—
Operating income−£2.9m−£4.0m−£1.4m−£3.8m−£12.1m−£5.5m£217,000−£1.4m−£4.7m−£2.4m
Net income−£2.1m−£3.4m−£1.3m−£3.5m−£21.3m−£7.0m−£3.4m−£1.3m£3.5m−£3.2m
Diluted earnings per share-0.01-0.01-0.00-0.01-0.07-0.06-0.04-0.000.01-0.01

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2016
Total assets£10.8m£9.3m£5.1m£6.1m£12.8m£33.2m£11.0m£7.3m£6.9m£8.6m
Cash and short-term investments£2.9m£1.9m£1.4m£3.2m£2.4m£5.0m£4.4m£866,152£476,909£2.0m
Total liabilities£4.7m£4.0m£2.8m£3.1m£6.3m£11.9m£8.2m£1.2m£1.1m£8.7m
Debt£1.3m£1.0m£1.0m£1.0m£1.3m£1.5m£4.8m£503,620£570,429£7.6m
Shareholders' equity£6.1m£5.3m£2.2m£3.0m£6.4m£21.3m£2.7m£6.1m£5.8m−£115,660
Shares outstanding414m395m355m307m304m122m96m414m414m414m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2016
Cash from operations−£1.6m−£3.2m−£1.7m£1.0m−£7.7m−£12.9m£2.1m−£908,254−£2.6m−£1.7m
Capital spending−£190,000−£327,000−£41,000−£157,000−£760,000−£7.3m−£1.6m−£96,217−£358,685−£668,900
Free cash flow−£1.8m−£3.5m−£1.7m£845,000−£8.5m−£20.1m£445,000−£1.0m−£2.9m−£2.3m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Mar 2023
Revenue£6.8m£4.2m£5.3m£3.1m£3.7m£2.4m£2.9m£1.5m
Gross profit£4.1m£1.1m£2.2m£917,000£2.3m£1.3m£1.4m£893,500
Operating income−£7,000−£2.9m−£1.5m−£2.4m−£120,000−£1.3m−£1.2m−£531,000
Net income£221,000−£2.3m−£894,000−£2.5m−£66,000−£1.2m−£1.0m−£515,000
Diluted earnings per share0.00-0.01-0.00-0.01-0.00-0.00-0.00-0.00
Cash from operations—−£1.0m—−£2.0m—−£1.0m——
Total assets£10.8m£10.6m£9.3m£9.8m£5.1m£4.8m£6.1m£6.1m
Cash and short-term investments£2.9m£3.7m£1.9m£3.7m£1.4m£2.0m£3.2m£3.2m
Debt£385,000£911,000£913,000£864,000£842,000£818,000£795,000—
Shareholders' equity£6.1m£6.3m£5.3m£6.4m£2.2m£1.8m£3.0m£3.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue39.6%-1.1%—
Operating income-9.4%-12.3%—
Net income-15.0%-21.1%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin42.8%45.2%26.2%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-17.5-7.4-21.6-9.7-0.9-5.8-26.9
Price to sales3.43.04.58.37.03.517.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.